Indication

Miosis induction during ocular surgery

Miosis induction during ocular surgery is an intraoperative clinical procedure and pharmacologically targeted state rather than a pathological disease. Read more about Miosis induction during ocular surgery

11 drugs 11 manufacturers

Advertisement

Drugs that treat it

Common Miosis induction during ocular surgery therapies.

Showing 10–11 of 11 drugs

PILOCARPINE HCL

PARASYMPATHETIC MIOTICS·OCULAR HYPERTENSION·+3
Amneal Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Miosis induction during ocular surgery preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Miosis induction during ocular surgery.

Miosis induction during ocular surgery is an intraoperative clinical procedure and pharmacologically targeted state rather than a pathological disease.

It involves the intentional, rapid constriction of the pupil in patients undergoing ophthalmic interventions, such as cataract extraction, penetrating keratoplasty, iridectomy, or anterior chamber reconstruction.

This state is physiologically characterized by the contraction of the iris sphincter muscle and ciliary body, typically stimulated through intracameral parasympathomimetic agents.

Mechanistically, this constriction centers the iris, draws peripheral tissue away from the anterior chamber angle to protect the intraocular structures, and helps stabilize or secure implanted intraocular lenses while reducing post-procedural intraocular pressure spikes.

Personalize your experience

Follow Miosis induction during ocular surgery and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it